
Ozempic
Productby Novo Nordisk
Heard in 206 episodes across 102 shows since Oct 2025
Ozempic is a prescription injectable medicine containing semaglutide, a GLP-1 receptor agonist. It is used with diet and exercise to improve blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease; semaglutide can also suppress appetite and reduce body weight, although weight management is associated with the separate Wegovy brand.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Ozempic per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 19 | 0.09‰ | 2 |
| Oct 20 | 0.10‰ | 4 |
| Oct 21 | 0.12‰ | 2 |
| Oct 22 | 0.12‰ | 1 |
| Oct 23 | 0.11‰ | 2 |
| Oct 24 | 0.11‰ | 2 |
| Oct 25 | 0.12‰ | 2 |
| Oct 27 | 0.10‰ | 3 |
| Oct 28 | 0.11‰ | 3 |
| Oct 29 | 0.14‰ | 4 |
| Oct 30 | 0.13‰ | 1 |
| Oct 31 | 0.12‰ | 1 |
| Nov 1 | 0.13‰ | 3 |
| Nov 2 | 0.13‰ | 1 |
| Nov 3 | 0.17‰ | 7 |
| Nov 4 | 0.16‰ | 2 |
| Nov 5 | 0.15‰ | 3 |
| Nov 6 | 0.17‰ | 3 |
| Nov 7 | 0.16‰ | 1 |
| Nov 8 | 0.16‰ | 3 |
| Nov 9 | 0.22‰ | 8 |
| Nov 10 | 0.18‰ | 3 |
| Nov 11 | 0.18‰ | 1 |
| Nov 12 | 0.19‰ | 4 |
| Nov 14 | 0.19‰ | 5 |
| Nov 16 | 0.12‰ | 2 |
| Nov 17 | 0.11‰ | 2 |
| Nov 18 | 0.12‰ | 2 |
| Nov 19 | 0.13‰ | 5 |
| Nov 20 | 0.14‰ | 1 |
Email alert
Email me when Ozempic comes up on a podcast
One email a week at most, with the new episodes that mention Ozempic. Free, no account needed, unsubscribe in one click.
What experts have said about Ozempic
6 statements · 5 positive · 1 negative
Stopping Ozempic and GLP medications causes obesity, weight, and disease to return.
“as soon as you stop taking it, every study shows that obesity returns, weight gain, disease gain”
Open the episode · Get Healthy, with Gary Brecka, Andrew Huberman, and Sean O'MaraListen at 4:18:55
Semaglutide patent expirations enable Sandoz to sell cheaper generic versions.
“that's paving the way for generic drug companies like Sandoz to sell cheaper versions of this key ingredient”
Open the episode · Novartis Slumps, Sandoz Gains, Computacenter UpListen at 3:16
Ozempic reduced Hari’s intake and produced 42 pounds of first-year weight loss.
“It's why I went from eating 3,200 calories a day to about 1,800. It's why I lost 42 pounds in the first year.”
Open the episode · Best of Big Technology: How Ozempic Changes Our Bodies, Minds, and Economy — With Johann HariListen at 17:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
206 episodes featuring Ozempic, newest first
- Nov 20, 2026
Rogan and Baker test America’s vulnerabilities from AI to IranThe Joe Rogan ExperienceNov 20, 2026 - Nov 20, 2026
Small actions confront life’s biggest constraintsThe Jordan Harbinger ShowNov 20, 2026 - Nov 19, 2026
AI and fragile infrastructure reshape the case for independent thinkingSarah Westall - Business Game ChangersNov 19, 2026 - Nov 19, 2026
Bostrom urges caution without freezing superintelligenceThe a16z ShowNov 19, 2026 - Nov 19, 2026
Trump’s summit, AI’s IPO and the politics of pediatric obesityThe HeadlinesNov 19, 2026 - Nov 19, 2026
Cancer research maps disease from body-wide effects to preventionThe Rest Is ScienceNov 19, 2026